Clinical Global Impression
Screening 12-Lead Electrocardiogram Report (Originial ECGs must be kept in the patient medical charts.)
ECG
boolean
After 5 minutes in the semi-supine position, a 12-lead ECG (using an ECG machine of adequate standard) will be performed. Six limb leads, as specified in Einthoven (I, II, III) and Goldberger (aVR, aVL, aVF), and six precordial leads (V1-V6), according to Wilson will be used. Heart raete (HR) and P-R, QRS, and QTc intervals will be assessed. The occurence of de- or repolarization disorders, arryhtmic disorders, or other abnormalities will also be assessed as per exclusion criteria 1 and 2.
time
After 5 minutes in the semi-supine position, a 12-lead ECG (using an ECG machine of adequate standard) will be performed. Six limb leads, as specified in Einthoven (I, II, III) and Goldberger (aVR, aVL, aVF), and six precordial leads (V1-V6), according to Wilson will be used. Heart raete (HR) and P-R, QRS, and QTc intervals will be assessed. The occurence of de- or repolarization disorders, arryhtmic disorders, or other abnormalities will also be assessed as per exclusion criteria 1 and 2.
float
After 5 minutes in the semi-supine position, a 12-lead ECG (using an ECG machine of adequate standard) will be performed. Six limb leads, as specified in Einthoven (I, II, III) and Goldberger (aVR, aVL, aVF), and six precordial leads (V1-V6), according to Wilson will be used. Heart raete (HR) and P-R, QRS, and QTc intervals will be assessed. The occurence of de- or repolarization disorders, arryhtmic disorders, or other abnormalities will also be assessed as per exclusion criteria 1 and 2.
float
After 5 minutes in the semi-supine position, a 12-lead ECG (using an ECG machine of adequate standard) will be performed. Six limb leads, as specified in Einthoven (I, II, III) and Goldberger (aVR, aVL, aVF), and six precordial leads (V1-V6), according to Wilson will be used. Heart raete (HR) and P-R, QRS, and QTc intervals will be assessed. The occurence of de- or repolarization disorders, arryhtmic disorders, or other abnormalities will also be assessed as per exclusion criteria 1 and 2.
float
QTc Interval
float
ECG Finding
integer
ECG Abnormal
text
Unified Parkinson's Disease Rating Scale (UPDRS)
Epworth Sleep Scale (ESS)
Orthostatic Blood Pressure/ Pulse
Date
date
Semi-supine Heart Rate
float
Erect Heart Rate
float
Semi-Supine Systolic Blood Pressure
float
Semi-Supine Diastolic Blood Pressure
float
Erect Systolic Blood Pressure
float
Erect Diastolic Blood Pressure
float
Medication taken after Study 196 Completion Visit (Record all medications taken by the patient after the Study 196 Completion Visit/Follow-up, including those taken for Parkinson's Disease. Please enter only medications taken between Study Completion/Follow-up and the Re-Enrollment Screening Visit as well as any doses of Ropinirole IR taken during this period. Only applies to subjects who have re-enrolled in the study after completion at 36 months.
Medication
boolean
Drug Name
text
Start Date
date
End Date
date
Dose
text
Frequency
text
Administration Route
text
Administration Route
text